BioCentury
ARTICLE | Company News

Management tracks: E-Scape, Immunomedics

August 23, 2018 6:36 PM UTC

Neurodegeneration company E-Scape Bio Inc. (South San Francisco, Calif.) hired Julie Smith as president and CEO. Smith was president and CEO at Nuredis Inc. (Menlo Park, Calif.). Smith succeeds former CEO Leon Chen, who is a venture partner at OrbiMed. OrbiMed led E-Scape's $63 million series A round last July (see "E-Scape Emerges with $63M Series A").

Immunomedics Inc. (NASDAQ:IMMU) said Michael Garone resigned as CFO. Garone will remain at the company as VP, finance until May 18, 2019, which the company noted is one year from the date it submitted a BLA to FDA for lead candidate sacituzumab govitecan to treat metastatic triple-negative breast cancer (TNBC) in the third-line setting. Sacituzumab is under FDA Priority Review with a Jan. 18 PDUFA date...

BCIQ Company Profiles

Aitia

E-Scape Bio Inc.